iLite® Metabolic Panel
As metabolic therapeutics become increasingly sophisticated, researchers need reliable tools to evaluate biological activity across multiple pathways. The iLite® Metabolic Panel brings together key metabolic targets, enabling consistent functional assessment.
Fueling the Development of Next-Generation Metabolic Therapeutics
Metabolic Target Assays
The metabolic therapeutics landscape is evolving rapidly. New generations of obesity and diabetes treatments increasingly combine multiple mechanisms of action to achieve improved efficacy and patient outcomes. As therapeutic strategies become more advanced, teams need practical tools that can help them generate biologically relevant functional data faster.
The iLite® Metabolic Panel is a suite of assay-ready reporter gene assays designed to deliver biologically relevant functional data across key metabolic targets. The panel brings together key targets within a single reporter gene assay platform, enabling consistent functional assessment from discovery through development.
Built on a common cell engineering and reporter technology platform, the iLite Metabolic Panel enables direct comparison of activity across individual metabolic pathways while maintaining consistency in assay design, performance, and workflow.
Whether developing single-target agonists, dual agonists, or next-generation multi-target therapeutics, developers gain access to a scalable platform that supports confident decision-making throughout the development lifecycle.
Our Metabolic Assays Solutions
iLite® FGF-21 Assay Ready Cells
Cell-based measurement of FGF-21 signaling, supporting metabolic research and development of FGF-21 analogs or mimetics
iLite® GIP Assay Ready Cells
This iLite® GIP reporter assay provides cell-based functional studies of GIP and its receptor GIPR, supporting metabolic research and development of incretin-based therapeutics.
iLite® GLP-1 Assay Ready Cells
This iLite® GLP-1 reporter assay provides cell-based functional studies of GLP-1 and its receptor GLP1R, supporting metabolic research and development of incretin-based single- and multi-agonist therapeutics.
iLite® Insulin Assay Ready Cells
Robust, quantitative measurement of insulin receptor activation, facilitating characterization of insulin analogs and biosimilars
Didn't find what you were looking for?
We offer products customized to your needs. Our custom iLite® reporter-gene assays can be adapted to almost any target. We also offer custom ELISA plates and other products. In addition, you can take advantage of our service offerings and let us do the work for you.
One Platform. Multiple Pathways. Faster Development Decisions.
Built on Svar Life Science's proprietary iLite® dual-reporter technology, the Metabolic Panel provides a unified approach to functional characterization and potency assessment across metabolic drug programs.
Tailored for the development of next-generation therapeutics
Confident decision-making
driven by data that reflect the true biological function
Deeper mechanistic insights
through MoA-reflective functional reporter assays
Direct side-by-side comparison
of candidates and modalities through a unified engineered cell system with built-in normalization
Precise potency assessment
with high sensitivity and a broad dynamic range
High assay reproducibility and low variability
optimal for QC testing, validation and tech transfer
Robust immunogenicity testing
with high serum tolerance
Faster time-to-results with the assay ready cells format
The iLite® Assay Ready Cells format removes the complexity of routine cell culture, reducing workflow complexity compared with conventional cell-based assay approaches.
Developers can progress from thawing to readout within the same day, minimizing hands-on time while improving assay consistency across sites, studies, and development stages.

iLite News
Translating Complex Metabolic Biology into Functional Insight
Read post
Introducing the iLite® Metabolic Panel
Read post
Introducing the new iLite® C3a Assay Ready Cells
Read post
Improved Speed and Accuracy in Immunogenicity Testing
Read post
Transitioning to Second-Generation iLite Cells
Read postiLite Downloads
Systematic Analysis of Fc Mutations Designed to Modulate Functional Activity
Read post
Therapeutic Antibodies Trimmed with GlycINATOR® Lose Antibody-Dependent Cell-mediated Cytotoxicity
Read post
Quantification of Bispecific Antibody Mediated T-cell Activation
Read post
IL-6 Biology, Inhibitors & COVID-19
Read post
Mechanism-linked Potency Assays Drive Gene Therapy Success
Read post
Addressing the Analytical Gaps in Modern Therapeutic Development
Read post
Developing a Customizable Complement-Dependent Cytotoxicity Assay
Read post
Partnering for Success in a New Era of Advanced Therapeutics
Read post
The Immune Response to AAV Gene Therapy
Read post
How to Design Potency Assays for Gene Therapy Projects
Read post
A Cell-Based ADCC Bioassay Comparison
Read post
Quantification of the Neutralizing Antibody Response to Recombinant AAV Vectors
Read post
Svar Complement Assays: Analyzing How Drug Candidates Affect the Complement System
Read post
Assay Development in AAV Therapies: Engineering iLite® Cell Lines for Specific and Analytical Applic...
Read post
Measuring C5a With a Functional Bioassay
Read postContact our iLite team
Write us a message and a product specialist will get in touch